<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">bjcvs</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27074269</article-id><article-id pub-id-type="pmc">5062695</article-id><article-id pub-id-type="doi">10.5935/1678-9741.20160002</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Articles</subject></subj-group></article-categories><title-group><article-title>Prognosis and Complications of Diabetic Patients Undergoing Isolated
Coronary Artery Bypass Surgery</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Santos</surname><given-names>Karen Alcantara Queiroz</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/></contrib><contrib contrib-type="author"><name><surname>Berto</surname><given-names>Bharbara</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Sousa</surname><given-names>Alexandre Gon&#x000e7;alves</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>da Costa</surname><given-names>Fernando Augusto Alves</given-names></name><degrees>MSc</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Universidade Anhembi Morumbi, S&#x000e3;o Paulo, SP,
Brazil.</aff><aff id="aff2"><label>2</label>Hospital Benefic&#x000ea;ncia Portuguesa de S&#x000e3;o
Paulo, S&#x000e3;o Paulo, SP, Brazil.</aff><author-notes><corresp id="c1">Correspondence Address: Karen Alcantara Queiroz Santos Hospital
Benefic&#x000ea;ncia Portuguesa de S&#x000e3;o Paulo Rua Maestro Cardim, 769 -
Bela Vista - S&#x000e3;o Paulo, SP, Brazil - Zip code: 01323-001 E-mail:
<email>karenqueiroz_@hotmail.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Jan-Feb</season><year>2016</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Jan-Feb</season><year>2016</year></pub-date><volume>31</volume><issue>1</issue><fpage>7</fpage><lpage>14</lpage><history><date date-type="received"><day>21</day><month>9</month><year>2015</year></date><date date-type="accepted"><day>30</day><month>12</month><year>2015</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Objective:</title><p>Compare the prognosis and complications of diabetic and non-diabetic patients
undergoing isolated coronary artery bypass surgery at a hospital with a high
surgical volume.</p></sec><sec><title>Methods:</title><p>Data of patients who underwent coronary artery bypass surgery from June 2009
to July 2010 were analyzed. We selected diabetic and non-diabetic patients
and evaluated their postoperative and long-term prognosis based on clinical
complications. To reduce the disparity within the sample, statistical
analyses were performed using propensity scores.</p></sec><sec><title>Results:</title><p>We included 2,688 patients who underwent coronary artery bypass surgery; 36%
of them had diabetes, their mean age was 62.1&#x000b1;9.49 years and 70%
(1,884) of them were men. Patients with diabetes were older (63&#x000b1;9
years <italic>vs.</italic> 61&#x000b1;10 years; <italic>P</italic>&#x0003c;0.001),
more often obese (BMI&#x0003e;25 kg/m<sup>2</sup>: 70.7% <italic>vs.</italic>
64.5%; <italic>P</italic>&#x0003c;0.001), dyslipidemic (50.4%
<italic>vs.</italic> 41.1%; <italic>P</italic>&#x0003c;0.001), hypertensive
(89.2% <italic>vs.</italic> 78.7%; <italic>P</italic>&#x0003c;0.001), and
presented chronic renal failure (8.3% <italic>vs.</italic> 3.8%;
<italic>P</italic>&#x0003c;0.001). They also presented higher rates of acute
renal failure (5.6% <italic>vs.</italic> 2.7%, <italic>P</italic>&#x0003c;0.001),
infection (11.4% <italic>vs.</italic> 7.2%, <italic>P</italic>&#x0003c;0.001) and
mortality after one year (9.1% <italic>vs.</italic> 5.6%,
<italic>P</italic>&#x0003c;0.001). Pneumonia was more common among patients with
diabetes (7.7% <italic>vs.</italic> 4.0%, <italic>P</italic>&#x0003c;0.001).
According to propensity scoring, 430 patients (215 diabetics and 215
non-diabetics) had a mean age of 61.3&#x000b1;8.97 years, and 21.2% (91 of
430) were women. However, diabetes was not an independent factor for poor
prognosis.</p></sec><sec><title>Conclusion:</title><p>Patients with diabetes were at higher risk for postoperative complications
and mortality after undergoing coronary artery bypass surgery. However,
diabetes did not explain the poor prognosis of these patients after pairing
this factor with the propensity score.</p></sec></abstract><kwd-group><kwd>Diabetes Mellitus</kwd><kwd>Coronary Artery Bypass</kwd><kwd>Diabetes Complications</kwd><kwd>Cardiac Surgical Procedures</kwd><kwd>Comparative Study</kwd></kwd-group></article-meta></front><body><table-wrap id="t7" orientation="portrait" position="anchor"><table frame="hsides" rules="groups" style="background-color:#e6e7e8"><colgroup span="1"><col width="10%" span="1"/><col width="90%" span="1"/></colgroup><thead><tr style="border-bottom-style:solid;border-top:solid; border-bottom-width:medium"><th colspan="2" align="left" rowspan="1">
<bold>Abbreviations, acronyms &#x00026; symbols</bold>
</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">AMI</td><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;= Acute myocardial infarction</td></tr><tr><td rowspan="1" colspan="1">BMI</td><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;= Body mass index</td></tr><tr><td rowspan="1" colspan="1">CABG</td><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;= Coronary artery bypass grafting</td></tr><tr><td rowspan="1" colspan="1">CHF</td><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;= Congestive heart failure</td></tr><tr><td rowspan="1" colspan="1">CKD</td><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;= Chronic kidney disease</td></tr><tr><td rowspan="1" colspan="1">CVD</td><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;= Cardiovascular disease</td></tr><tr><td rowspan="1" colspan="1">DM</td><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;= Diabetes mellitus</td></tr><tr><td rowspan="1" colspan="1">HTN</td><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;= Hypertension</td></tr><tr><td rowspan="1" colspan="1">IOT-Re</td><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;= Reintubation rates</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>Diabetes mellitus (DM) is considered to be one of the most prevalent diseases in the
western world, constituting a true epidemic in urbanized societies. Its importance
is related not only to the increasing incidence of the disease, but also to its
extremely close relationship with atherosclerotic disease, which has a great impact
on morbidity and mortality worldwide. Estimates of the World Health Organization
show that worldwide prevalence of this disease may have an increase of 114% during
the next 20 years, leading to the emergence of 330 million new
cases<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>.
Brazil is following this global trend, and is included among the 10 countries with
the highest absolute number of individuals with DM<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup>. In this context, it is necessary to
remember that one of the main causes of mortality related to DM is cardiovascular
disease (CVD), especially coronary artery disease, accounting for 60% to 80% of
deaths among adults.</p><p>Patients diagnosed with DM represent approximately 25% of all patients undergoing
surgical or percutaneous revascularization procedures. They have a worse prognosis
in relation to coronary heart disease compared with patients who do not have DM, as
well as different prognoses when treated by percutaneous intervention with catheters
or surgery. Coronary artery bypass grafting (CABG) is nowadays the preferable
revascularization treatment of diabetic patients<sup>[<xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r4" ref-type="bibr">4</xref>]</sup>.</p><p>In relation to surgical treatment, several studies revealed higher morbidity and
perioperative mortality rates among patients with DM undergoing CABG. This finding
is probably related to the occurrence of perioperative myocardial infarction,
infections, respiratory failure, renal and cerebral complications, all of which
prolong hospitalization in these patients<sup>[<xref rid="r5" ref-type="bibr">5</xref>-<xref rid="r7" ref-type="bibr">7</xref>]</sup>. Moreover,
the presence of DM is considered to be an independent risk factor for postoperative
mortality after CABG, with an odds ratio of 1.73 for cardiovascular death and 2.94
for overall mortality<sup>[<xref rid="r8" ref-type="bibr">8</xref>,<xref rid="r9" ref-type="bibr">9</xref>]</sup>. In Brazil, a study shows
mortality as high as 11.8% in diabetic patients<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>. But another one with octogenarian
patients did not found differences in mortality<sup>[<xref rid="r11" ref-type="bibr">11</xref>]</sup>.</p><p>This study aims to compare the prognosis and complications of diabetic patients with
non-diabetic undergoing isolated CABG at a hospital with a high surgical volume.</p></sec><sec sec-type="methods"><title>METHODS</title><p>Patient evaluation was performed by collecting prospective data on patients
undergoing CABG at our hospital from June 2009 to July 2010. Three senior nurses at
the hospital were trained to collect these data using prespecified settings.
Patients were included in the database if they fulfilled the following inclusion
criteria: they were consecutive patients aged 18 years or older (no restrictions on
sex or race) and had undergone CABG. Patients were excluded if they had undergone
any other surgery, including cardiac surgery, in which isolated CABG or congenital
cardiac surgery was not performed.</p><p>From this sample, patients who underwent isolated CABG were selected, and this
population was then divided into those with DM and those without DM. For these
groups, postoperative prognoses with clinical complications, as well as long-term
outcomes, were evaluated by telephone interviews; these interviews were conducted
from the 30<sup>th</sup> day after surgery to one year after surgery.</p><p>Among the clinical complications that occurred following CABG, the following
variables were analyzed: perioperative acute myocardial infarction (AMI),
neurological complications, pulmonary complications, infectious complications,
cardiac arrhythmias, and multiple organ failure occurring within 30 days after the
surgery.</p><sec><title>Clinical complications were defined as follows:</title><list list-type="bullet"><list-item><p>Perioperative AMI was defined as: prolonged pain (&#x0003e; 20 minutes);
typical pain not improved by nitrates; elevation of cardiac enzymes
(CK-MB or troponin &#x0003e; 0.2 micrograms/ml); or a new alteration in
cardiac mobility or electrocardiogram series (at least two) showing new
changes in the ST/T segment or new Q waves of at least 0.03 seconds or
more than one-third of QRS in at least two contiguous leads;</p></list-item><list-item><p>Stroke (cerebrovascular accident) was defined as the persistence of motor
deficit for more than 72 hours or coma for more than 24 hours;</p></list-item><list-item><p>Acute renal failure was defined as serum creatinine level greater than
2.0 mg/dl, two times greater than the preoperative level, or the
necessity of dialysis by any method;</p></list-item><list-item><p>Infectious processes were defined as: Mediastinitis (defined as deep
infection involving muscles, bone and/or mediastinum, fulfilling the
following conditions: 1. open wound with tissue excision, 2. positive
cultures and 3. treatment with antibiotics); surface of thoracotomy
(infection involving thoracotomy and parasternal region fulfilling the
following conditions: 1. open wound with tissue excision, 2. positive
cultures and 3. treatment with antibiotics); superficial leg incision
(infection involving the site of dissection of mediastinal veins
fulfilling the following conditions: 1. open wound with tissue excision,
2. positive cultures and 3. treatment with antibiotics); and infections
related to venous catheters and the urinary tract.</p></list-item><list-item><p>Pulmonary complications were defined as prolonged mechanical ventilation
(i.e., the need for ventilation for more than 48 hours in the
postoperative period), acute respiratory distress syndrome, pulmonary
embolism or pneumonia (diagnosed by the following criteria: positive
cultures of sputum, blood or pleural fluid; empyema; or chest X-ray with
new infiltrates);</p></list-item><list-item><p>Cardiac arrhythmias that required intervention comprised atrial
fibrillation, atrial flutter, paroxysmal supraventricular tachycardia
and bradyarrhythmias;</p></list-item><list-item><p>Failure of multiple organs was defined as two or more systems with
compromised functioning.</p></list-item></list><p>All the hospital's cardiac surgery teams agreed to provide data for the
development of the database. The logistic EuroSCORE was individually calculated
for all patients (preoperative risk score) and expressed as the average of the
groups.</p><p>The project was submitted and approved by the Ethics Committee of the Institution
with CAEE number 43817015.2.0000.5483. Because this was a retrospective database
survey, an informed consent form was not given to the patients. The data
obtained from the database were confidentially treated by the research
center.</p></sec><sec><title>Statistical considerations</title><p>Initially, all variables were descriptively analyzed. For quantitative variables,
analyses were carried out by observing minimum and maximum values and
calculating the mean and standard deviation. For qualitative variables, absolute
and relative frequencies were calculated.</p><p>To compare the averages of the two groups, we used Student's t
test<sup>[<xref rid="r12" ref-type="bibr">12</xref>]</sup>, and when the assumption of data normality was
rejected, we used the nonparametric Mann-Whitney <italic>U</italic>
test<sup>[<xref rid="r12" ref-type="bibr">12</xref>]</sup>. To test the homogeneity between proportions, we used
the chi-square test or the Fisher's exact test<sup>[<xref rid="r12" ref-type="bibr">12</xref>]</sup>.</p></sec><sec><title>Propensity Scoring</title><p>To minimize the bias resulting from collecting data at different times and in a
nonrandomized way, and to balance the characteristics of patients within the
sample, patients in the DM groups were combined using a propensity score,
defined as the conditional probability of belonging to a determined group. This
procedure corresponds to selecting patients from the diabetic group who were
similar to patients from the non-diabetic group.</p><p>First, a logistic regression model<sup>[<xref rid="r13" ref-type="bibr">13</xref>]</sup> was created using the variable group as the
dependent variable. The most relevant confounders [sex, body mass index
(BMI in kg/m<sup>2</sup>), chronic kidney disease (CKD), hypertension (HTN),
previous cerebrovascular accident, congestive heart failure (CHF), endotracheal
reintubation, and cardiopulmonary bypass support] were used as predictive
factors, and the corresponding tolerance margin was a 0.05 logit. Next, paired
cases were selected based on the propensity logistic regression score. This
model was built based on a sample of patients paired by a propensity of 01:01,
without substitution or repetition. The significance level used for the tests
was 5%.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>The study included 2,688 diabetic and non-diabetic patients who underwent CABG, with
an average age of 62.1 years and 70% (1,884) males (<xref ref-type="table" rid="t1">Table 1</xref>). Patients with DM accounted for 36% (990 of 2,688) of the total
population. Patients with DM were older on average (63&#x000b1;9 years
<italic>vs.</italic> 61&#x000b1;10 years for non-diabetics;
<italic>P</italic>&#x0003c;0.001), more were men (64.6% diabetics <italic>vs.</italic>
73.3% non-diabetics; <italic>P</italic>&#x0003c;0.001), and more were overweight, with
the majority having a BMI&#x0003e;25 kg/m<sup>2</sup> (70.7% diabetics
<italic>vs.</italic> 64.5% non-diabetics, <italic>P</italic>&#x0003c;0.001). In
addition, patients with DM were more often former smokers (42.0%
<italic>vs.</italic> 38.4% of non-diabetics; <italic>P</italic>&#x0003c;0.001),
dyslipidemic (50.4% <italic>vs.</italic> 41.1% of non-diabetics;
<italic>P</italic>&#x0003c;0.001) and presented CKD (8.3% <italic>vs.</italic> 3.8%
non-diabetics, <italic>P</italic>&#x0003c;0.001). Of these, the majority of patients were
being treated with dialysis (28.1% of patients with DM <italic>vs.</italic> 14.1% of
non-diabetics; <italic>P</italic>&#x0003c;0.043), had HTN (89.2% of patients with DM
<italic>vs.</italic> 78.7% of non-diabetics; <italic>P</italic>&#x0003c;0.001), more
often had a history of cerebrovascular accident (7.4% of patients with DM
<italic>vs.</italic> 4.0% of non-diabetics; <italic>P</italic>=0.001),
peripheral arterial disease (6.0% of patients with DM <italic>vs.</italic> 4.0%
non-diabetics; <italic>P</italic>=0.017) and were more likely to present CHF (3.3%
of patients with DM <italic>vs.</italic> 1.2% non-diabetics;
<italic>P</italic>&#x0003c;0.001). The expected mortality rate calculated by EuroSCORE
was also higher in patients with DM: 2.6&#x000b1;2.4 compared with 2.2&#x000b1;2.0 in
non-diabetics (<italic>P</italic>&#x0003c;0.001).</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Descriptive values [average &#x000b1; standard deviation or n
(%)] of preoperative variables according to the study group.</p></caption><table frame="hsides" rules="all"><colgroup width="25%" span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr style="border-top-style:solid; border-top-width:medium"><th rowspan="1" colspan="1">&#x000a0;</th><th colspan="3" align="center" rowspan="1">Original Cohort (n=2,688)</th></tr><tr><th rowspan="1" colspan="1">&#x000a0;</th><th colspan="2" align="center" rowspan="1">Diabetes</th><th rowspan="2" align="center" colspan="1"><italic>P</italic> value</th></tr><tr><th rowspan="1" colspan="1">Variables</th><th align="center" rowspan="1" colspan="1">No (n=1,698)</th><th align="center" rowspan="1" colspan="1">Yes (n=990)</th></tr></thead><tbody><tr style="border-top-style:solid; border-top-width:medium"><td rowspan="1" colspan="1">Age</td><td align="center" rowspan="1" colspan="1">61&#x000b1;10</td><td align="center" rowspan="1" colspan="1">63&#x000b1;9</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001<sup><xref ref-type="table-fn" rid="TFN1">[1]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">Male sex</td><td align="center" rowspan="1" colspan="1">1,245 (73.3)</td><td align="center" rowspan="1" colspan="1">639 (64.6)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001<sup><xref ref-type="table-fn" rid="TFN2">[2]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">Body mass index (kg/m<sup><xref ref-type="table-fn" rid="TFN2">2</xref></sup>)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x0003c; 25</td><td align="center" rowspan="1" colspan="1">584 (35.5)</td><td align="center" rowspan="1" colspan="1">283 (29.3)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001<sup><xref ref-type="table-fn" rid="TFN2">[2]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;25-30</td><td align="center" rowspan="1" colspan="1">774 (47.1)</td><td align="center" rowspan="1" colspan="1">427 (44.3)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x0003e;30</td><td align="center" rowspan="1" colspan="1">285 (17.4)</td><td align="center" rowspan="1" colspan="1">255 (26.4)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">Smoking history:</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Smokers</td><td align="center" rowspan="1" colspan="1">318 (18.7)</td><td align="center" rowspan="1" colspan="1">104 (10.5)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001<sup><xref ref-type="table-fn" rid="TFN2">[2]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Former smokers</td><td align="center" rowspan="1" colspan="1">652 (38.4)</td><td align="center" rowspan="1" colspan="1">416 (42.0)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001<sup><xref ref-type="table-fn" rid="TFN2">[2]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Never smoked</td><td align="center" rowspan="1" colspan="1">728 (42.9)</td><td align="center" rowspan="1" colspan="1">470 (47.5)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001<sup><xref ref-type="table-fn" rid="TFN2">[2]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Dyslipidemia</td><td align="center" rowspan="1" colspan="1">697 (41.1)</td><td align="center" rowspan="1" colspan="1">499 (50.4)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001<sup><xref ref-type="table-fn" rid="TFN2">[2]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Chronic kidney disease</td><td align="center" rowspan="1" colspan="1">64 (3.8)</td><td align="center" rowspan="1" colspan="1">82 (8.3)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001<sup><xref ref-type="table-fn" rid="TFN2">[2]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;In dialysis (n=146)</td><td align="center" rowspan="1" colspan="1">9 (14.1)</td><td align="center" rowspan="1" colspan="1">23 (28.1)</td><td align="center" rowspan="1" colspan="1">0.043<sup><xref ref-type="table-fn" rid="TFN2">[2]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Hypertension</td><td align="center" rowspan="1" colspan="1">1,336 (78.7)</td><td align="center" rowspan="1" colspan="1">883 (89.2)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001<sup><xref ref-type="table-fn" rid="TFN2">[2]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Previous cerebrovascular
accident</td><td align="center" rowspan="1" colspan="1">67 (4.0)</td><td align="center" rowspan="1" colspan="1">73 (7.4)</td><td align="center" rowspan="1" colspan="1">0.001<sup><xref ref-type="table-fn" rid="TFN2">[2]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Chronic obstructive pulmonary
disease</td><td align="center" rowspan="1" colspan="1">128 (7.5)</td><td align="center" rowspan="1" colspan="1">56 (5.7)</td><td align="center" rowspan="1" colspan="1">0.062<sup><xref ref-type="table-fn" rid="TFN2">[2]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Peripheral arterial disease</td><td align="center" rowspan="1" colspan="1">67 (4.0)</td><td align="center" rowspan="1" colspan="1">59 (6.0)</td><td align="center" rowspan="1" colspan="1">0.017<sup><xref ref-type="table-fn" rid="TFN2">[2]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Cerebrovascular disease</td><td align="center" rowspan="1" colspan="1">27 (1.6)</td><td align="center" rowspan="1" colspan="1">21 (2.1)</td><td align="center" rowspan="1" colspan="1">0.316<sup><xref ref-type="table-fn" rid="TFN2">[2]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Serum creatinine</td><td align="center" rowspan="1" colspan="1">1.3&#x000b1;0.6</td><td align="center" rowspan="1" colspan="1">1.4&#x000b1;0.9</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001<sup><xref ref-type="table-fn" rid="TFN1">[1]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Prior CABG</td><td align="center" rowspan="1" colspan="1">20 (1.2)</td><td align="center" rowspan="1" colspan="1">18 (1.8)</td><td align="center" rowspan="1" colspan="1">0.175<sup><xref ref-type="table-fn" rid="TFN2">[2]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Prior acute myocardial
infarction</td><td align="center" rowspan="1" colspan="1">801 (47.2)</td><td align="center" rowspan="1" colspan="1">442 (44.7)</td><td align="center" rowspan="1" colspan="1">0.205<sup><xref ref-type="table-fn" rid="TFN2">[2]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Congestive heart failure</td><td align="center" rowspan="1" colspan="1">21 (1.2)</td><td align="center" rowspan="1" colspan="1">33 (3.3)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001<sup><xref ref-type="table-fn" rid="TFN2">[2]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Arrhythmia</td><td align="center" rowspan="1" colspan="1">81 (4.8)</td><td align="center" rowspan="1" colspan="1">54 (5.5)</td><td align="center" rowspan="1" colspan="1">0.433<sup><xref ref-type="table-fn" rid="TFN2">[2]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Ejection fraction</td><td align="center" rowspan="1" colspan="1">65.6&#x000b1;11.9</td><td align="center" rowspan="1" colspan="1">63.5&#x000b1;12.4</td><td align="center" rowspan="1" colspan="1">0.005<sup><xref ref-type="table-fn" rid="TFN1">[1]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;EuroSCORE logistics</td><td align="center" rowspan="1" colspan="1">2.2&#x000b1;2.0</td><td align="center" rowspan="1" colspan="1">2.6&#x000b1;2.4</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001<sup><xref ref-type="table-fn" rid="TFN3">[3]</xref></sup></td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><label>[1]</label><p>Descriptive level of probability determined by the Student's t-test.</p></fn><fn id="TFN2"><label>[2]</label><p>Descriptive level of probability determined by the chi-square test.</p></fn><fn id="TFN3"><label>[3]</label><p>Descriptive level of probability determined by the nonparametric
Mann-Whitney <italic>U</italic> test.</p></fn></table-wrap-foot></table-wrap><p>In relation to medical treatment, diabetics had the highest rates of previous use of
medications such as calcium-channel blockers (22.8% of patients with DM
<italic>vs.</italic> 18.1% of non-diabetic patients; <italic>P</italic>=0.003),
angiotensin-converting enzyme inhibitors (50.5% of patients with DM
<italic>vs.</italic> 46.5% of non-diabetic patients; <italic>P</italic>=0.046)
and angiotensin II receptor blockers (20.2% of patients with DM <italic>vs.</italic>
16.0% of non-diabetic patients; <italic>P</italic>=0.005), as shown in <xref ref-type="table" rid="t2">Table 2</xref>.</p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Absolute and relative frequencies of the use of medications in the
preoperative period according to the study group.</p></caption><table frame="hsides" rules="all"><colgroup width="25%" span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr style="border-top-style:solid; border-top-width:medium"><th rowspan="3" align="left" colspan="1">Variables</th><th colspan="3" align="center" rowspan="1">Original Cohort (n=2,688)</th></tr><tr><th colspan="2" align="center" rowspan="1">Diabetes</th><th rowspan="2" align="center" colspan="1"><italic>P</italic> value</th></tr><tr><th align="center" rowspan="1" colspan="1">No (n=1,698)</th><th align="center" rowspan="1" colspan="1">Yes (n=990)</th></tr></thead><tbody><tr style="border-top-style:solid; border-top-width:medium"><td rowspan="1" colspan="1">Anticoagulant</td><td align="center" rowspan="1" colspan="1">8 (0.5)</td><td align="center" rowspan="1" colspan="1">6 (0.6)</td><td align="center" rowspan="1" colspan="1">0.639<sup><xref ref-type="table-fn" rid="TFN4">[1]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">Acetylsalicylic acid</td><td align="center" rowspan="1" colspan="1">1,158 (68.2)</td><td align="center" rowspan="1" colspan="1">710 (71.2)</td><td align="center" rowspan="1" colspan="1">0.056<sup><xref ref-type="table-fn" rid="TFN4">[1]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">Beta blocker</td><td align="center" rowspan="1" colspan="1">1,107 (65.2)</td><td align="center" rowspan="1" colspan="1">611 (61.7)</td><td align="center" rowspan="1" colspan="1">0.070<sup><xref ref-type="table-fn" rid="TFN4">[1]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">Oral nitrates</td><td align="center" rowspan="1" colspan="1">1,106 (65.1)</td><td align="center" rowspan="1" colspan="1">577 (58.3)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.00<sup><xref ref-type="table-fn" rid="TFN4">[1]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">Calcium-channel blocker</td><td align="center" rowspan="1" colspan="1">308 (18.1)</td><td align="center" rowspan="1" colspan="1">226 (22.8)</td><td align="center" rowspan="1" colspan="1">0.003<sup><xref ref-type="table-fn" rid="TFN4">[1]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">Diuretics</td><td align="center" rowspan="1" colspan="1">431 (25.4)</td><td align="center" rowspan="1" colspan="1">282 (28.5)</td><td align="center" rowspan="1" colspan="1">0.079<sup><xref ref-type="table-fn" rid="TFN4">[1]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">Angiotensin-converting enzyme inhibitors</td><td align="center" rowspan="1" colspan="1">790 (46.5)</td><td align="center" rowspan="1" colspan="1">500 (50.5)</td><td align="center" rowspan="1" colspan="1">0.046<sup><xref ref-type="table-fn" rid="TFN4">[1]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">Angiotensin II receptor blockers</td><td align="center" rowspan="1" colspan="1">271 (16.0)</td><td align="center" rowspan="1" colspan="1">200 (20.2)</td><td align="center" rowspan="1" colspan="1">0.005<sup><xref ref-type="table-fn" rid="TFN4">[1]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">Inotropic agents</td><td align="center" rowspan="1" colspan="1">3 (0.2)</td><td align="center" rowspan="1" colspan="1">2 (0.2)</td><td align="center" rowspan="1" colspan="1">1.000<sup><xref ref-type="table-fn" rid="TFN5">[2]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">Statins</td><td align="center" rowspan="1" colspan="1">1,164 (68.6)</td><td align="center" rowspan="1" colspan="1">646 (65.3)</td><td align="center" rowspan="1" colspan="1">0.079<sup><xref ref-type="table-fn" rid="TFN4">[1]</xref></sup></td></tr></tbody></table><table-wrap-foot><fn id="TFN4"><label>[1]</label><p>Descriptive level of probability determined by the chi-square test.</p></fn><fn id="TFN5"><label>[2]</label><p>Descriptive level of probability determined by the Fisher1s exact
test.</p></fn></table-wrap-foot></table-wrap><p>Intraoperatively, diabetic patients underwent more procedures with the support of
extracorporeal circulation (88.9% of patients with DM <italic>vs.</italic> 85.6% of
non-diabetic patients; <italic>P</italic>=0.016), and a higher percentage of deaths
occurred during surgery in patients with DM (0.5%) than in non-diabetic patients
(0%; <italic>P</italic>=0.007) as can be observed in <xref ref-type="table" rid="t3">Table 3</xref>.</p><table-wrap id="t3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Descriptive values [average &#x000b1; standard deviation or n
(%)] of surgical variables according to the study group.</p></caption><table frame="hsides" rules="all"><colgroup width="25%" span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr style="border-top-style:solid; border-top-width:medium"><th rowspan="3" align="left" colspan="1">Variables</th><th colspan="3" align="center" rowspan="1">Original Cohort (n=2,688)</th></tr><tr><th colspan="2" align="center" rowspan="1">Diabetes</th><th rowspan="2" align="center" colspan="1"><italic>P</italic> value</th></tr><tr><th align="center" rowspan="1" colspan="1">No (n=1,698)</th><th align="center" rowspan="1" colspan="1">Yes (n=990)</th></tr></thead><tbody><tr style="border-top-style:solid; border-top-width:medium"><td rowspan="1" colspan="1">Emergency surgery/emergency</td><td align="center" rowspan="1" colspan="1">16 (0.9)</td><td align="center" rowspan="1" colspan="1">10 (1.0)</td><td align="center" rowspan="1" colspan="1">0.862<sup><xref ref-type="table-fn" rid="TFN8">[3]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">Extracorporeal circulation</td><td align="center" rowspan="1" colspan="1">1,454 (85.6)</td><td align="center" rowspan="1" colspan="1">880 (88.9)</td><td align="center" rowspan="1" colspan="1">0.016<sup><xref ref-type="table-fn" rid="TFN7">[2]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">Clamping time</td><td align="center" rowspan="1" colspan="1">43.5&#x000b1;19.1</td><td align="center" rowspan="1" colspan="1">44.3&#x000b1;19.8</td><td align="center" rowspan="1" colspan="1">0.332<sup><xref ref-type="table-fn" rid="TFN6">[1]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">Intraoperative death</td><td align="center" rowspan="1" colspan="1">----</td><td align="center" rowspan="1" colspan="1">5 (0.5)</td><td align="center" rowspan="1" colspan="1">0.007<sup><xref ref-type="table-fn" rid="TFN8">[3]</xref></sup></td></tr></tbody></table><table-wrap-foot><fn id="TFN6"><label>[1]</label><p>Descriptive level of probability by the Student1s t-test. </p></fn><fn id="TFN7"><label>[2]</label><p>Descriptive level of probability by the chi-square test. </p></fn><fn id="TFN8"><label>[3]</label><p>Descriptive level of probability by the Fisher1s exact test.</p></fn></table-wrap-foot></table-wrap><p>In the postoperative phase, patients with DM required greater use of transfused blood
products (66.6% <italic>vs.</italic> 60.4% of non-diabetic patients;
<italic>P</italic>=0.001) and had higher reintubation rates (IOT-Re) (6.5% of
patients with DM <italic>vs.</italic> 3.4% of non-diabetic patients;
<italic>P</italic>&#x0003c;0.001) (<xref ref-type="table" rid="t4">Table 4</xref>).
Blood glucose was monitored during the first 24 hours after surgery. Patients with
DM had higher average levels of blood glucose (197.2&#x000b1;36.6
<italic>vs.</italic> 166.9&#x000b1;26.1 mg/ dL for non-diabetic patients;
<italic>P</italic>&#x0003c;0.001) and used intravenous insulin at higher rates (30.6%
<italic>vs.</italic> 16.0% for non-diabetic patients;
<italic>P</italic>&#x0003c;0.001).</p><table-wrap id="t4" orientation="portrait" position="float"><label>Table 4</label><caption><p>Descriptive values [average &#x000b1; standard deviation or n
(%)] of postoperative variables according to the study group.
Original Cohort (n=2,688)</p></caption><table frame="hsides" rules="all"><colgroup width="25%" span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr style="border-top-style:solid; border-top-width:medium"><th rowspan="3" align="left" colspan="1">Variables</th><th colspan="3" align="center" rowspan="1">Original Cohort (n=2,688)</th></tr><tr><th colspan="2" align="center" rowspan="1">Diabetes</th><th rowspan="2" align="center" colspan="1"><italic>P</italic> value</th></tr><tr><th align="center" rowspan="1" colspan="1">No (n=1,698)</th><th align="center" rowspan="1" colspan="1">Yes (n=990)</th></tr></thead><tbody><tr style="border-top-style:solid; border-top-width:medium"><td rowspan="1" colspan="1">Transfusion</td><td align="center" rowspan="1" colspan="1">1,025 (60.4)</td><td align="center" rowspan="1" colspan="1">659 (66.6)</td><td align="center" rowspan="1" colspan="1">0.001<sup><xref ref-type="table-fn" rid="TFN10">[2]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">Orotracheal reintubation during hospitalization</td><td align="center" rowspan="1" colspan="1">58 (3.4)</td><td align="center" rowspan="1" colspan="1">64 (6.5)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001<sup><xref ref-type="table-fn" rid="TFN10">[2]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">Average blood glucose (24 hours)</td><td align="center" rowspan="1" colspan="1">166.9&#x000b1;26.1</td><td align="center" rowspan="1" colspan="1">197.2&#x000b1;36.6</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001<sup><xref ref-type="table-fn" rid="TFN9">[1]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">Higher value of blood glucose (24 hours)</td><td align="center" rowspan="1" colspan="1">216.1&#x000b1;46.1</td><td align="center" rowspan="1" colspan="1">274.2&#x000b1;60.6</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001<sup><xref ref-type="table-fn" rid="TFN9">[1]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">Lower value of blood glucose (24 hours)</td><td align="center" rowspan="1" colspan="1">126.5&#x000b1;26.2</td><td align="center" rowspan="1" colspan="1">131.5&#x000b1;37.7</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001<sup><xref ref-type="table-fn" rid="TFN9">[1]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">Use of intravenous insulin (24 hours)</td><td align="center" rowspan="1" colspan="1">272 (16.0)</td><td align="center" rowspan="1" colspan="1">303 (30.6)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001<sup><xref ref-type="table-fn" rid="TFN10">[2]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">Readmission to the intensive care unit</td><td align="center" rowspan="1" colspan="1">117 (6.9)</td><td align="center" rowspan="1" colspan="1">70 (7.1)</td><td align="center" rowspan="1" colspan="1">0.856<sup><xref ref-type="table-fn" rid="TFN10">[2]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">Time spent in intensive care unit</td><td align="center" rowspan="1" colspan="1">2.1&#x000b1;3.5</td><td align="center" rowspan="1" colspan="1">2.3&#x000b1;4.4</td><td align="center" rowspan="1" colspan="1">0.285<sup><xref ref-type="table-fn" rid="TFN11">[4]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">Time of hospitalization</td><td align="center" rowspan="1" colspan="1">11.0&#x000b1;11.7</td><td align="center" rowspan="1" colspan="1">12.9&#x000b1;18.3</td><td align="center" rowspan="1" colspan="1">0.331<sup><xref ref-type="table-fn" rid="TFN11">[4]</xref></sup></td></tr></tbody></table><table-wrap-foot><fn id="TFN9"><label>[1]</label><p>Descriptive level of probability of Student's t-test. </p></fn><fn id="TFN10"><label>[2]</label><p>Descriptive level of probability of chi-square test. </p></fn><fn id="TFN11"><label>[4]</label><p>Descriptive level of probability of Mann-Whitney U-test.</p></fn></table-wrap-foot></table-wrap><p>In terms of complications, the DM patient group showed higher rates of CKD (5.6%
<italic>vs.</italic> 2.7% for non-diabetic patients;
<italic>P</italic>&#x0003c;0.001), greater dialysis rates (2.2% <italic>vs.</italic> 0.7%
for non-diabetic patients; <italic>P</italic>&#x0003c;0.001) and more infections (11.4%
<italic>vs.</italic> 7.2% for non-diabetic patients;
<italic>P</italic>&#x0003c;0.001), with mediastinitis (2.7% <italic>vs.</italic> 1.5% for
non-diabetic patients; <italic>P</italic>&#x0003c;0.031) and urinary tract infections
(3.2% <italic>vs.</italic> 1.2% for non-diabetic patients;
<italic>P</italic>&#x0003c;0.001) being the most common (<xref ref-type="table" rid="t5">Table 5</xref>). Pneumonia was the most common postoperative infection, though
it was not grouped in this study with the other infections: 7.7% of patients with DM
<italic>vs.</italic> 4.0% of non-diabetic patients
(<italic>P</italic>&#x0003c;0.001). Patients with DM also showed higher rates of
mortality after one year, with a death rate of 9.1% compared with 5.6% in the
non-diabetic patient group (<italic>P</italic>&#x0003c;0.001).</p><table-wrap id="t5" orientation="portrait" position="float"><label>Table 5</label><caption><p>Absolute and relative frequencies of complications according to the study
group.</p></caption><table frame="hsides" rules="all"><colgroup width="25%" span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr style="border-top-style:solid; border-top-width:medium"><th rowspan="3" colspan="1">Complications</th><th colspan="3" align="center" rowspan="1">Original cohort (n=2688)</th></tr><tr><th colspan="2" align="center" rowspan="1">Diabetes</th><th rowspan="2" align="center" colspan="1"><italic>P</italic> value</th></tr><tr><th align="center" rowspan="1" colspan="1">No (n=1,698)</th><th align="center" rowspan="1" colspan="1">Yes (n=990)</th></tr></thead><tbody><tr style="border-top-style:solid; border-top-width:medium"><td rowspan="1" colspan="1">Operative</td><td align="center" rowspan="1" colspan="1">60 (3.5)</td><td align="center" rowspan="1" colspan="1">35 (3.5)</td><td align="center" rowspan="1" colspan="1">0.998<sup><xref ref-type="table-fn" rid="TFN12">[1]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">Perioperative acute myocardial infarction</td><td align="center" rowspan="1" colspan="1">23 (1.4)</td><td align="center" rowspan="1" colspan="1">9 (0.9)</td><td align="center" rowspan="1" colspan="1">0.304<sup><xref ref-type="table-fn" rid="TFN12">[1]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">Cerebrovascular accident</td><td align="center" rowspan="1" colspan="1">21 (1.2)</td><td align="center" rowspan="1" colspan="1">21 (2.1)</td><td align="center" rowspan="1" colspan="1">0.075<sup><xref ref-type="table-fn" rid="TFN12">[1]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">Acute renal failure</td><td align="center" rowspan="1" colspan="1">46 (2.7)</td><td align="center" rowspan="1" colspan="1">55 (5.6)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001<sup><xref ref-type="table-fn" rid="TFN12">[1]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">Dialysis</td><td align="center" rowspan="1" colspan="1">11 (0.7)</td><td align="center" rowspan="1" colspan="1">22 (2.2)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001<sup><xref ref-type="table-fn" rid="TFN12">[1]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">Infections</td><td align="center" rowspan="1" colspan="1">123 (7.2)</td><td align="center" rowspan="1" colspan="1">113 (11.4)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001<sup><xref ref-type="table-fn" rid="TFN12">[1]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">Mediastinitis</td><td align="center" rowspan="1" colspan="1">26 (1.5)</td><td align="center" rowspan="1" colspan="1">27 (2.7)</td><td align="center" rowspan="1" colspan="1">0.031 <sup><xref ref-type="table-fn" rid="TFN12">[1]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">Urinary tract infection</td><td align="center" rowspan="1" colspan="1">20 (1.2)</td><td align="center" rowspan="1" colspan="1">32 (3.2)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001<sup><xref ref-type="table-fn" rid="TFN12">[1]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">Prolonged mechanical ventilation</td><td align="center" rowspan="1" colspan="1">32 (1.9)</td><td align="center" rowspan="1" colspan="1">20 (2.0)</td><td align="center" rowspan="1" colspan="1">0.806<sup><xref ref-type="table-fn" rid="TFN12">[1]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">Pneumonia</td><td align="center" rowspan="1" colspan="1">67 (4.0)</td><td align="center" rowspan="1" colspan="1">76 (7.7)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001<sup><xref ref-type="table-fn" rid="TFN12">[1]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">Arrhythmia</td><td align="center" rowspan="1" colspan="1">292 (17.2)</td><td align="center" rowspan="1" colspan="1">171 (17.3)</td><td align="center" rowspan="1" colspan="1">0.960<sup><xref ref-type="table-fn" rid="TFN12">[1]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">Death within 30 days</td><td align="center" rowspan="1" colspan="1">49 (2.9)</td><td align="center" rowspan="1" colspan="1">40 (4.1)</td><td align="center" rowspan="1" colspan="1">0.105<sup><xref ref-type="table-fn" rid="TFN12">[1]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">Death within 1 year</td><td align="center" rowspan="1" colspan="1">95 (5.6)</td><td align="center" rowspan="1" colspan="1">90 (9.1)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001<sup><xref ref-type="table-fn" rid="TFN12">[1]</xref></sup></td></tr></tbody></table><table-wrap-foot><fn id="TFN12"><label>[1]</label><p>Descriptive level of probability by the chi-square test.</p></fn></table-wrap-foot></table-wrap><p>To elucidate the role of DM in causing the complications found in this study, we
performed a propensity score analysis, whose results are shown in <xref ref-type="table" rid="t6">Table 6</xref>. In this analysis, a total of 430
patients were analyzed (215 with DM and 215 without DM) with an average age of 61
years, of which 21.16% (91 of 430) were female. DM was not found to be a separate,
independent risk factor for poor prognosis among these patients. In relation to
postoperative complications, renal failure (occurring in 1.4% of DM patients
<italic>vs.</italic> 0.9% of non-diabetic patients; <italic>P</italic>=1.0) was
not found to be a significant factor after pairing. Infectious complications
developed in 7.4% of patients with DM compared with 6.5% of non-diabetic patients
(<italic>P</italic>=0.705). Finally, the mortality rates in patients with DM
were evaluated after 30 days and found to be 1.4% diabetics <italic>vs.</italic>
2.3% for non-diabetic patients (<italic>P</italic>=0.724); after one year, mortality
rates in patients with DM reached 3.3% <italic>vs.</italic> 5.6% in non-diabetic
patients (<italic>P</italic>=0.245).</p><table-wrap id="t6" orientation="portrait" position="float"><label>Table 6</label><caption><p>Descriptive values [mean &#x000b1; standard deviation or n (%)]
of the variables after pairing according to the study group.</p></caption><table frame="hsides" rules="all"><colgroup width="25%" span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr style="border-top-style:solid; border-top-width:medium"><th rowspan="1" colspan="1">&#x000a0;</th><th colspan="3" align="center" rowspan="1">Paired Cohort (n=430)</th></tr><tr><th rowspan="1" colspan="1">&#x000a0;</th><th colspan="2" align="center" rowspan="1">Diabetes</th><th align="center" rowspan="1" colspan="1">&#x000a0;</th></tr><tr><th rowspan="1" colspan="1">Variables</th><th align="center" rowspan="1" colspan="1">No (n=215)</th><th align="center" rowspan="1" colspan="1">Yes (n=215)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic> value</th></tr></thead><tbody><tr style="border-top-style:solid; border-top-width:medium"><td rowspan="1" colspan="1">Age</td><td align="center" rowspan="1" colspan="1">61&#x000b1;10</td><td align="center" rowspan="1" colspan="1">62&#x000b1;9</td><td align="center" rowspan="1" colspan="1">0.700<sup><xref ref-type="table-fn" rid="TFN13">[1]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">Male sex</td><td align="center" rowspan="1" colspan="1">169 (78.6)</td><td align="center" rowspan="1" colspan="1">170 (79.1)</td><td align="center" rowspan="1" colspan="1">0.906<sup><xref ref-type="table-fn" rid="TFN14">[2]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">Body mass index (kg/m<sup>2</sup>)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x0003c; 25</td><td align="center" rowspan="1" colspan="1">69 (32.1)</td><td align="center" rowspan="1" colspan="1">69 (32.1)</td><td align="center" rowspan="1" colspan="1">0.959<sup><xref ref-type="table-fn" rid="TFN14">[2]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;25-30</td><td align="center" rowspan="1" colspan="1">117 (54.4)</td><td align="center" rowspan="1" colspan="1">115 (53.5)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x0003e;30</td><td align="center" rowspan="1" colspan="1">29 (13.5)</td><td align="center" rowspan="1" colspan="1">31 (14.4)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Dyslipidemia</td><td align="center" rowspan="1" colspan="1">94 (43.7)</td><td align="center" rowspan="1" colspan="1">115 (53.5)</td><td align="center" rowspan="1" colspan="1">0.043<sup><xref ref-type="table-fn" rid="TFN14">[2]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Chronic kidney disease</td><td align="center" rowspan="1" colspan="1">1 (0.5)</td><td align="center" rowspan="1" colspan="1">2 (0.9)</td><td align="center" rowspan="1" colspan="1">1.000<sup><xref ref-type="table-fn" rid="TFN15">[3]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Hypertension</td><td align="center" rowspan="1" colspan="1">207 (96.3)</td><td align="center" rowspan="1" colspan="1">207 (96.3)</td><td align="center" rowspan="1" colspan="1">1.000<sup><xref ref-type="table-fn" rid="TFN14">[2]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Previous stroke</td><td align="center" rowspan="1" colspan="1">4 (1.9)</td><td align="center" rowspan="1" colspan="1">2 (0.9)</td><td align="center" rowspan="1" colspan="1">0.685<sup><xref ref-type="table-fn" rid="TFN15">[3]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Peripheral arterial disease</td><td align="center" rowspan="1" colspan="1">7 (3.3)</td><td align="center" rowspan="1" colspan="1">16 (7.4)</td><td align="center" rowspan="1" colspan="1">0.054<sup><xref ref-type="table-fn" rid="TFN14">[2]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Cerebrovascular disease</td><td align="center" rowspan="1" colspan="1">4 (1.9)</td><td align="center" rowspan="1" colspan="1">4 (1.9)</td><td align="center" rowspan="1" colspan="1">1.000<sup><xref ref-type="table-fn" rid="TFN15">[3]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Prior coronary artery bypass
surgery</td><td align="center" rowspan="1" colspan="1">2 (0.9)</td><td align="center" rowspan="1" colspan="1">1 (0.5)</td><td align="center" rowspan="1" colspan="1">1.000<sup><xref ref-type="table-fn" rid="TFN15">[3]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Previous acute myocardial
infarction</td><td align="center" rowspan="1" colspan="1">94 (43.7)</td><td align="center" rowspan="1" colspan="1">104 (48.4)</td><td align="center" rowspan="1" colspan="1">0.333<sup><xref ref-type="table-fn" rid="TFN14">[2]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Arrhythmia</td><td align="center" rowspan="1" colspan="1">11 (5.1)</td><td align="center" rowspan="1" colspan="1">7 (3.3)</td><td align="center" rowspan="1" colspan="1">0.336<sup><xref ref-type="table-fn" rid="TFN14">[2]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Ejection fraction</td><td align="center" rowspan="1" colspan="1">67.2&#x000b1;9.7</td><td align="center" rowspan="1" colspan="1">65.1&#x000b1;12.5</td><td align="center" rowspan="1" colspan="1">0.230<sup><xref ref-type="table-fn" rid="TFN13">[1]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;EuroSCORE</td><td align="center" rowspan="1" colspan="1">2.1&#x000b1;1.7</td><td align="center" rowspan="1" colspan="1">1.9&#x000b1;1.4</td><td align="center" rowspan="1" colspan="1">0.811<sup><xref ref-type="table-fn" rid="TFN16">[4]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Average blood glucose (24
hours)</td><td align="center" rowspan="1" colspan="1">170.7&#x000b1;27.2</td><td align="center" rowspan="1" colspan="1">192.0&#x000b1;32.1</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001<sup><xref ref-type="table-fn" rid="TFN13">[1]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Higher value of blood glucose</td><td align="center" rowspan="1" colspan="1">219.5&#x000b1;49.4</td><td align="center" rowspan="1" colspan="1">263.1&#x000b1;52.8</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001<sup><xref ref-type="table-fn" rid="TFN13">[1]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Use of intravenous insulin (24
hours)</td><td align="center" rowspan="1" colspan="1">39 (18.1)</td><td align="center" rowspan="1" colspan="1">63 (29.3)</td><td align="center" rowspan="1" colspan="1">0.007<sup><xref ref-type="table-fn" rid="TFN14">[2]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Time spent in the intensive care
unit</td><td align="center" rowspan="1" colspan="1">2.1&#x000b1;4.4</td><td align="center" rowspan="1" colspan="1">1.6&#x000b1;0.9</td><td align="center" rowspan="1" colspan="1">0.297<sup><xref ref-type="table-fn" rid="TFN16">[4]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Time of hospitalization</td><td align="center" rowspan="1" colspan="1">11.6&#x000b1;19.7</td><td align="center" rowspan="1" colspan="1">9.8&#x000b1;10.6</td><td align="center" rowspan="1" colspan="1">0.088<sup><xref ref-type="table-fn" rid="TFN16">[4]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Surgeries</td><td align="center" rowspan="1" colspan="1">5 (2.3)</td><td align="center" rowspan="1" colspan="1">2 (0.9)</td><td align="center" rowspan="1" colspan="1">0.449<sup><xref ref-type="table-fn" rid="TFN15">[3]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Perioperative acute myocardial
infarction</td><td align="center" rowspan="1" colspan="1">3 (1.4)</td><td align="center" rowspan="1" colspan="1">_</td><td align="center" rowspan="1" colspan="1">0.248<sup><xref ref-type="table-fn" rid="TFN15">[3]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Cerebrovascular accident</td><td align="center" rowspan="1" colspan="1">1 (0.5)</td><td align="center" rowspan="1" colspan="1">3 (1.4)</td><td align="center" rowspan="1" colspan="1">0.623<sup><xref ref-type="table-fn" rid="TFN15">[3]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Acute renal failure</td><td align="center" rowspan="1" colspan="1">2 (0.9)</td><td align="center" rowspan="1" colspan="1">3 (1.4)</td><td align="center" rowspan="1" colspan="1">1.000<sup><xref ref-type="table-fn" rid="TFN15">[3]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Dialysis</td><td align="center" rowspan="1" colspan="1">1 (0.5)</td><td align="center" rowspan="1" colspan="1">_</td><td align="center" rowspan="1" colspan="1">1.000<sup><xref ref-type="table-fn" rid="TFN15">[3]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Infections</td><td align="center" rowspan="1" colspan="1">14 (6.5)</td><td align="center" rowspan="1" colspan="1">16 (7.4)</td><td align="center" rowspan="1" colspan="1">0.705<sup><xref ref-type="table-fn" rid="TFN14">[2]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Mediastinitis</td><td align="center" rowspan="1" colspan="1">4 (1.9)</td><td align="center" rowspan="1" colspan="1">3 (1.4)</td><td align="center" rowspan="1" colspan="1">1.000<sup><xref ref-type="table-fn" rid="TFN15">[3]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Urinary tract infection</td><td align="center" rowspan="1" colspan="1">3 (1.4)</td><td align="center" rowspan="1" colspan="1">6 (2.8)</td><td align="center" rowspan="1" colspan="1">0.503<sup><xref ref-type="table-fn" rid="TFN15">[3]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Prolonged mechanical
ventilation</td><td align="center" rowspan="1" colspan="1">2 (0.9)</td><td align="center" rowspan="1" colspan="1">_</td><td align="center" rowspan="1" colspan="1">0.499<sup><xref ref-type="table-fn" rid="TFN15">[3]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Pneumonia</td><td align="center" rowspan="1" colspan="1">6 (2.8)</td><td align="center" rowspan="1" colspan="1">6 (2.8)</td><td align="center" rowspan="1" colspan="1">1.000<sup><xref ref-type="table-fn" rid="TFN14">[2]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Arrhythmia</td><td align="center" rowspan="1" colspan="1">32 (14.9)</td><td align="center" rowspan="1" colspan="1">31 (14.4)</td><td align="center" rowspan="1" colspan="1">0.892<sup><xref ref-type="table-fn" rid="TFN14">[2]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Death within 30 days</td><td align="center" rowspan="1" colspan="1">5 (2.3)</td><td align="center" rowspan="1" colspan="1">3 (1.4)</td><td align="center" rowspan="1" colspan="1">0.724<sup><xref ref-type="table-fn" rid="TFN15">[3]</xref></sup></td></tr><tr><td rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Death within 1 year</td><td align="center" rowspan="1" colspan="1">12 (5.6)</td><td align="center" rowspan="1" colspan="1">7 (3.3)</td><td align="center" rowspan="1" colspan="1">0.245<sup><xref ref-type="table-fn" rid="TFN14">[2]</xref></sup></td></tr></tbody></table><table-wrap-foot><fn id="TFN13"><label>[1]</label><p>Descriptive level of probability by the Student's t-test. </p></fn><fn id="TFN14"><label>[2]</label><p>Descriptive level of probability by the chi-square test. </p></fn><fn id="TFN15"><label>[3]</label><p>Descriptive level of probability by the Fisher's exact test. </p></fn><fn id="TFN16"><label>[4]</label><p>Descriptive level of probability by the nonparametric Mann-Whitney
U-test.</p></fn></table-wrap-foot></table-wrap></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>In this study, patients with DM had higher rates of mortality and morbidity (mainly
renal disease and infectious) after CABG. However, after performing propensity
scoring, DM was not found to be an independent predictive factor for these
findings.</p><p>Patients with DM who underwent CABG more often suffered from acute renal failure
(5.6%). These data were confirmed by Adalsteinsson et al.<sup>[<xref rid="r14" ref-type="bibr">14</xref>]</sup> performed in their
retrospective study, which enrolled 1,626 patients who underwent CABG surgery in
Iceland from 2001 to 2012. They compared 261 (16%) patients with DM with 1,365
non-diabetic patients, and 14% <italic>vs.</italic> 9% of these patients,
respectively, developed acute renal failure (<italic>P</italic>=0.02). In other
analyses, Kubal et al.<sup>[<xref rid="r15" ref-type="bibr">15</xref>]</sup> showed that insulin-dependent DM was associated with an
increased incidence of acute renal failure (adjusted odds ratio, 4.15;
<italic>P</italic>=0.002).</p><p>The predisposition of patients with DM to infectious complications after cardiac
surgery has frequently been suggested by different authors<sup>[<xref rid="r16" ref-type="bibr">16</xref>-<xref rid="r21" ref-type="bibr">21</xref>]</sup> but with some exceptions<sup>[<xref rid="r6" ref-type="bibr">6</xref>,<xref rid="r14" ref-type="bibr">14</xref>,<xref rid="r17" ref-type="bibr">17</xref>,<xref rid="r22" ref-type="bibr">22</xref>]</sup>, in which no trend of incidence was
detectable. The main reasons for the predisposition to the cited infections are due
to the strong association between DM and angiopathy, neuropathy and hyperglycemia.
Diabetic patients present an increased risk for postoperative infections due to
depreciated host defense mechanisms, such as impaired as wound healing and
granulocyte function, decreased cellular immunity, impaired complement function, and
reduced immune response, which may be influenced by the glycemic
control<sup>[<xref rid="r20" ref-type="bibr">20</xref>-<xref rid="r24" ref-type="bibr">24</xref>]</sup>.</p><p>In addition to increasing the risk for postoperative infections in CABG, DM was
associated with a significantly higher incidence of late mortality (up to one year)
and related cardiac events. In our study, intraoperative mortality was also higher
in patients with DM compared with non-diabetic patients (0.5% <italic>vs.</italic>
0%; <italic>P</italic>=0.007). Recent studies by Szabo et al.<sup>[<xref rid="r25" ref-type="bibr">25</xref>]</sup> e Kubal et
al.<sup>[<xref rid="r15" ref-type="bibr">15</xref>]</sup>
concur with our findings, reporting an intrahospital mortality of 2.6% and 2.4% for
their DM patient populations, respectively. However, Kubal et al.<sup>[<xref rid="r15" ref-type="bibr">15</xref>]</sup>, after adjusting the
propensity score, showed that there was no longer a significant association between
DM and hospital mortality, as in our study. Therefore, the 30-day mortality rate in
our study was 4.1% in patients with DM <italic>vs.</italic> 2.9% in non-diabetic
patients (<italic>P</italic>=0.105). Similar findings were also obtained by Szabo et
al.<sup>[<xref rid="r25" ref-type="bibr">25</xref>]</sup>, who
reported a mortality rate 2.6% for DM patients <italic>vs.</italic> 1.6% for
non-diabetic patients (<italic>P</italic>=0.15).</p><p>Our study did not assess subtypes of DM patients, because DM type I (DM1) may have a
higher severity, as demonstrated in another study<sup>[<xref rid="r26" ref-type="bibr">26</xref>]</sup>, in which patients with DM1 presented a
two-fold increase in the risk of death compared to that in non-diabetic patients,
and DM type 2 patients had a small but significant increased risk of death than that
of the same population. Another possible explanation for the null association
between DM and mortality may be the low number of patients used in the
comparison.</p><p>The mortality rate did not remain an independent risk factor after the propensity
score analysis. In our analysis, patients with DM presented more comorbidities, such
as more-severe atherosclerotic disease and more complications. Therefore, they had a
more urgent indication for surgery and a significantly higher usage of
extracorporeal circulation, which can contribute to a greater chance of
complications after surgery.</p><p>This study had several limitations. First, this was an observational study, and we
can speak of causality only in terms of association. At the time of data collection,
this analysis had not been planned, and for this reason, this study was not able to
evaluate the outcomes for specific types of DM. The fact that the data were
collected from medical records may have affected the quality and completeness of the
data, which depended on notes from health professionals. In addition, this study
used a database from a single institution (one center), and although compiled by
different surgical teams, this method limits the generalizability of our
results.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>Finally, we found that patients with diabetes were at higher risk for postoperative
complications and mortality after undergoing CABG, however, in our study, diabetes
did not explain the poor prognosis of these patients after pairing this factor with
the propensity score.</p><table-wrap id="t8" orientation="portrait" position="anchor"><table frame="hsides" rules="all"><colgroup span="1"><col width="10%" span="1"/><col width="90%" span="1"/></colgroup><thead><tr><th colspan="2" align="left" rowspan="1">
<bold>Authors' roles &#x00026; responsibilities</bold>
</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">KAQS</td><td rowspan="1" colspan="1">Conception and design study; realization of operations and/or
trials; statistical analysis; analysis and/or data interpretation;
manuscript writing or critical review of its content; final
manuscript approval</td></tr><tr><td rowspan="1" colspan="1">BB</td><td rowspan="1" colspan="1">Conception and design study; realization of operations and/or
trials; statistical analysis; analysis and/or data interpretation;
manuscript writing or critical review of its content; final
manuscript approval</td></tr><tr><td rowspan="1" colspan="1">AGS</td><td rowspan="1" colspan="1">Manuscript writing or critical review of its content; final
manuscript approval</td></tr><tr><td rowspan="1" colspan="1">FAAC</td><td rowspan="1" colspan="1">Manuscript writing or critical review of its content; final
manuscript approval</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn><fn fn-type="other"><p>This study was carried out at Hospital Benefic&#x000ea;ncia Portuguesa de
S&#x000e3;o Paulo, S&#x000e3;o Paulo, SP, Brazil.</p></fn><fn fn-type="supported-by"><p>No financial support.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wild</surname><given-names>S</given-names></name><name><surname>Roglic</surname><given-names>G</given-names></name><name><surname>Green</surname><given-names>A</given-names></name><name><surname>Sicree</surname><given-names>R</given-names></name><name><surname>King</surname><given-names>H</given-names></name></person-group><article-title>Global prevalence of diabetes: estimates for the year 2000 and
projections for 2030</article-title><source>Diabetes Care</source><year>2004</year><volume>27</volume><issue>5</issue><fpage>1047</fpage><lpage>1053</lpage><pub-id pub-id-type="pmid">15111519</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Centemero</surname><given-names>MP</given-names></name><name><surname>Cherobin</surname><given-names>JC</given-names></name><name><surname>Conti</surname><given-names>KVF</given-names></name><name><surname>Ohe</surname><given-names>LN</given-names></name><name><surname>Mallmann</surname><given-names>N</given-names></name><name><surname>Abizaid</surname><given-names>A</given-names></name><etal/></person-group><article-title>Doen&#x000e7;a arterial coron&#x000e1;ria e diabetes: do tratamento
farmacol&#x000f3;gico aos procedimentos de
revasculariza&#x000e7;&#x000e3;o</article-title><source>Rev Bras Cardiol Invas</source><year>2009</year><volume>17</volume><issue>3</issue><fpage>398</fpage><lpage>413</lpage></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farkouh</surname><given-names>ME</given-names></name><name><surname>Domanski</surname><given-names>M</given-names></name><name><surname>Sleeper</surname><given-names>LA</given-names></name><name><surname>Siami</surname><given-names>FS</given-names></name><name><surname>Dangas</surname><given-names>G</given-names></name><name><surname>Mack</surname><given-names>M</given-names></name><etal/></person-group><article-title>Strategies for multivessel revascularization in patients with
diabetes</article-title><source>N Engl J Med</source><year>2012</year><volume>367</volume><issue>25</issue><fpage>2375</fpage><lpage>2384</lpage><pub-id pub-id-type="pmid">23121323</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deb</surname><given-names>S</given-names></name><name><surname>Wijeysundera</surname><given-names>HC</given-names></name><name><surname>Ko</surname><given-names>DT</given-names></name><name><surname>Tsubota</surname><given-names>H</given-names></name><name><surname>Hill</surname><given-names>S</given-names></name><name><surname>Fremes</surname><given-names>SE</given-names></name></person-group><article-title>Coronary artery bypass graft surgery vs percutaneous
interventions in coronary revascularization: a systematic
review</article-title><source>JAMA</source><year>2013</year><volume>310</volume><issue>19</issue><fpage>2086</fpage><lpage>2095</lpage><pub-id pub-id-type="pmid">24240936</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luciani</surname><given-names>N</given-names></name><name><surname>Nasso</surname><given-names>G</given-names></name><name><surname>Gaudino</surname><given-names>M</given-names></name><name><surname>Abbate</surname><given-names>A</given-names></name><name><surname>Glieca</surname><given-names>F</given-names></name><name><surname>Alessandrini</surname><given-names>F</given-names></name><etal/></person-group><article-title>Coronary artery bypass grafting in type II diabetic patients: a
comparison between insulin-dependent and non-insulindependent patients at
short- and mid-term follow-up</article-title><source>Ann Thorac Surg</source><year>2003</year><volume>76</volume><issue>4</issue><fpage>1149</fpage><lpage>1154</lpage><pub-id pub-id-type="pmid">14530003</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van den Berghe</surname><given-names>G</given-names></name><name><surname>Wouters</surname><given-names>P</given-names></name><name><surname>Weekers</surname><given-names>F</given-names></name><name><surname>Verwaest</surname><given-names>C</given-names></name><name><surname>Bruyninckx</surname><given-names>F</given-names></name><name><surname>Schetz</surname><given-names>M</given-names></name><etal/></person-group><article-title>Intensive insulin therapy in critically ill
patients</article-title><source>N Engl J Med</source><year>2001</year><volume>345</volume><issue>19</issue><fpage>1359</fpage><lpage>1367</lpage><pub-id pub-id-type="pmid">11794168</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kappetein</surname><given-names>AP</given-names></name><name><surname>Head</surname><given-names>SJ</given-names></name><name><surname>Morice</surname><given-names>MC</given-names></name><name><surname>Banning</surname><given-names>AP</given-names></name><name><surname>Serruys</surname><given-names>PW</given-names></name><name><surname>Mohr</surname><given-names>FW</given-names></name><etal/></person-group><article-title>Treatment of complex coronary artery disease in patients with
diabetes: 5-year results comparing outcomes of bypass surgery and
percutaneous coronary intervention in the SYNTAX trial</article-title><source>Eur J Cardiothorac Surg</source><year>2013</year><volume>43</volume><issue>5</issue><fpage>1006</fpage><lpage>1013</lpage><pub-id pub-id-type="pmid">23413014</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Keefe</surname><given-names>JH Jr</given-names></name><name><surname>Milles</surname><given-names>JM</given-names></name><name><surname>Harris</surname><given-names>WH</given-names></name><name><surname>Moe</surname><given-names>RM</given-names></name><name><surname>McCallister</surname><given-names>BD</given-names></name></person-group><article-title>Improving the adverse cardiovascular prognosis of type 2
diabetes</article-title><source>Mayo Clin Proc</source><year>1999</year><volume>74</volume><issue>2</issue><fpage>171</fpage><lpage>180</lpage><pub-id pub-id-type="pmid">10069357</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kannel</surname><given-names>WB</given-names></name></person-group><article-title>Lipids, diabetes, and coronary heart disease: insights from the
Framingham Study</article-title><source>Am Heart J</source><year>1985</year><volume>110</volume><issue>5</issue><fpage>1100</fpage><lpage>1107</lpage><pub-id pub-id-type="pmid">4061265</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>S&#x000e1;</surname><given-names>MPBO</given-names></name><name><surname>Soares</surname><given-names>EF</given-names></name><name><surname>Santos</surname><given-names>CA</given-names></name><name><surname>Figueiredo</surname><given-names>OJ</given-names></name><name><surname>Lima</surname><given-names>ROA</given-names></name><name><surname>Escobar</surname><given-names>RR</given-names></name><etal/></person-group><article-title>Mortalidade perioperat&#x000f3;ria em diab&#x000e9;ticos submetidos
&#x000e0; cirurgia de revasculariza&#x000e7;&#x000e3;o
mioc&#x000e1;rdica</article-title><source>Rev Col Bras Cir</source><year>2012</year><volume>39</volume><issue>1</issue><fpage>22</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">22481702</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pivatto J&#x000fa;nior</surname><given-names>F</given-names></name><name><surname>Pereira</surname><given-names>EMC</given-names></name><name><surname>Valle</surname><given-names>FH</given-names></name><name><surname>Teixeira Filho</surname><given-names>GF</given-names></name><name><surname>Nesralla</surname><given-names>IA</given-names></name><name><surname>Sant'Anna</surname><given-names>JRM</given-names></name><etal/></person-group><article-title>Does diabetes mellitus increase immediate surgical risk in
octogenarian patients submitted to coronary artery bypass graft
surgery?</article-title><source>Rev Bras Cir Cardiovasc</source><year>2012</year><volume>27</volume><issue>4</issue><fpage>600</fpage><lpage>606</lpage><pub-id pub-id-type="pmid">23515733</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Rosner</surname><given-names>B</given-names></name></person-group><source>Fundamentals of biostatistics</source><edition>2nd ed</edition><publisher-loc>Boston</publisher-loc><publisher-name>PWS Publishers</publisher-name><year>1986</year><fpage>584</fpage><lpage>584</lpage></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Hosmer</surname><given-names>DW</given-names></name><name><surname>Lemeshow</surname><given-names>S</given-names></name></person-group><source>Applied logistic regression</source><publisher-loc>New York</publisher-loc><publisher-name>John Wiley &#x00026; Sons</publisher-name><year>1989</year><fpage>307</fpage><lpage>307</lpage></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adalsteinsson</surname><given-names>JA</given-names></name><name><surname>Axelsson</surname><given-names>TA</given-names></name><name><surname>Helgason</surname><given-names>D</given-names></name><name><surname>Arnadottir</surname><given-names>LO</given-names></name><name><surname>Johannesdottir</surname><given-names>H</given-names></name><name><surname>Geirsson</surname><given-names>A</given-names></name><etal/></person-group><article-title>Early outcome in diabetic patients following coronary artery
bypass grafting</article-title><source>Laeknabladid</source><year>2014</year><volume>100</volume><issue>10</issue><fpage>507</fpage><lpage>512</lpage><pub-id pub-id-type="pmid">25310039</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kubal</surname><given-names>C</given-names></name><name><surname>Srinivasan</surname><given-names>AK</given-names></name><name><surname>Grayson</surname><given-names>AD</given-names></name><name><surname>Fabri</surname><given-names>BM</given-names></name><name><surname>Chalmers</surname><given-names>JA</given-names></name></person-group><article-title>Effect of risk-adjusted diabetes on mortality and morbidity after
coronary artery bypass surgery</article-title><source>Ann Thorac Surg</source><year>2005</year><volume>79</volume><issue>5</issue><fpage>1570</fpage><lpage>1576</lpage><pub-id pub-id-type="pmid">15854935</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bucerius</surname><given-names>J</given-names></name><name><surname>Gummert</surname><given-names>JF</given-names></name><name><surname>Walther</surname><given-names>T</given-names></name><name><surname>Doll</surname><given-names>N</given-names></name><name><surname>Falk</surname><given-names>V</given-names></name><name><surname>Onnasch</surname><given-names>JF</given-names></name><etal/></person-group><article-title>Impact of diabetes mellitus on cardiac surgery
outcome</article-title><source>Thorac Cardiovasc Surg</source><year>2003</year><volume>51</volume><issue>1</issue><fpage>11</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">12587082</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crabtree</surname><given-names>TD</given-names></name><name><surname>Codd</surname><given-names>JE</given-names></name><name><surname>Fraser</surname><given-names>VJ</given-names></name><name><surname>Bailey</surname><given-names>MS</given-names></name><name><surname>Olsen</surname><given-names>MA</given-names></name><name><surname>Damiano</surname><given-names>RJ Jr</given-names></name></person-group><article-title>Multivariate analysis of risk factors for deep and superficial
sternal infection after coronary artery bypass grafting at a tertiary care
medical center</article-title><source>Semin Thorac Cardiovasc Surg</source><year>2004</year><volume>16</volume><issue>1</issue><fpage>53</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">15366688</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fish</surname><given-names>LH</given-names></name><name><surname>Weaver</surname><given-names>TW</given-names></name><name><surname>Moore</surname><given-names>AL</given-names></name><name><surname>Steel</surname><given-names>LG</given-names></name></person-group><article-title>Value of postoperative blood glucose in predicting complications
and length of stay after coronary artery bypass grafting</article-title><source>Am J Cardiol</source><year>2003</year><volume>92</volume><issue>1</issue><fpage>74</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">12842253</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golden</surname><given-names>SH</given-names></name><name><surname>Peart-Vigilance</surname><given-names>C</given-names></name><name><surname>Kao</surname><given-names>WH</given-names></name><name><surname>Brancati</surname><given-names>FL</given-names></name></person-group><article-title>Perioperative glycemic control and the risk of infectious
complications in a cohort of adults with diabetes</article-title><source>Diabetes Care</source><year>1999</year><volume>22</volume><issue>9</issue><fpage>1408</fpage><lpage>1414</lpage><pub-id pub-id-type="pmid">10480501</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guvener</surname><given-names>M</given-names></name><name><surname>Pasaoglu</surname><given-names>I</given-names></name><name><surname>Demircin</surname><given-names>M</given-names></name><name><surname>Oc</surname><given-names>M</given-names></name></person-group><article-title>Perioperative hyperglycemia is a strong correlate of
postoperative infection in type II diabetic patients after coronary artery
bypass grafting</article-title><source>Endocr J</source><year>2002</year><volume>49</volume><issue>5</issue><fpage>531</fpage><lpage>537</lpage><pub-id pub-id-type="pmid">12507271</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McMahon</surname><given-names>MM</given-names></name><name><surname>Bistrian</surname><given-names>BR</given-names></name></person-group><article-title>Host defenses and susceptibility to infection in patients with
diabetes mellitus</article-title><source>Infect Dis Clin North Am</source><year>1995</year><volume>9</volume><issue>1</issue><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">7769211</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leibovici</surname><given-names>L</given-names></name><name><surname>Yehezkelli</surname><given-names>Y</given-names></name><name><surname>Porter</surname><given-names>A</given-names></name><name><surname>Regev</surname><given-names>A</given-names></name><name><surname>Krauze</surname><given-names>I</given-names></name><name><surname>Harell</surname><given-names>D</given-names></name></person-group><article-title>Influence of diabetes mellitus and glycaemic control on the
characteristics and outcome of common infections</article-title><source>Diabet Med</source><year>1996</year><volume>13</volume><issue>5</issue><fpage>457</fpage><lpage>463</lpage><pub-id pub-id-type="pmid">8737028</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gallagher</surname><given-names>S</given-names></name><name><surname>Kapur</surname><given-names>A</given-names></name><name><surname>Lovell</surname><given-names>MJ</given-names></name><name><surname>Jones</surname><given-names>DA</given-names></name><name><surname>Kirkwood</surname><given-names>A</given-names></name><name><surname>Hassan</surname><given-names>S</given-names></name><etal/></person-group><article-title>Impact of diabetes mellitus and renal insufficiency on 5-year
mortality following coronary artery bypass graft surgery: a cohort study of
4869 UK patients</article-title><source>Eur J Cardiothorac Surg</source><year>2014</year><volume>45</volume><issue>6</issue><fpage>1075</fpage><lpage>1081</lpage><pub-id pub-id-type="pmid">24448075</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baker</surname><given-names>RA</given-names></name><name><surname>Hallsworth</surname><given-names>LJ</given-names></name><name><surname>Knight</surname><given-names>JL</given-names></name></person-group><article-title>Stroke after coronary artery bypass grafting</article-title><source>Ann Thorac Surg</source><year>2005</year><volume>80</volume><issue>5</issue><fpage>1746</fpage><lpage>1750</lpage><pub-id pub-id-type="pmid">16242450</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szabo</surname><given-names>Z</given-names></name><name><surname>Hakanson</surname><given-names>E</given-names></name><name><surname>Svedjeholm</surname><given-names>R</given-names></name></person-group><article-title>Early postoperative outcome and medium-term survival in 540
diabetic and 2239 nondiabetic patients undergoing coronary artery bypass
grafting</article-title><source>Ann Thorac Surg</source><year>2002</year><volume>74</volume><issue>3</issue><fpage>712</fpage><lpage>719</lpage><pub-id pub-id-type="pmid">12238829</pub-id></element-citation></ref><ref id="r26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holzmann</surname><given-names>MJ</given-names></name><name><surname>Rathsman</surname><given-names>B</given-names></name><name><surname>Eliasson</surname><given-names>B</given-names></name><name><surname>Kuhl</surname><given-names>J</given-names></name><name><surname>Svensson</surname><given-names>AM</given-names></name><name><surname>Nystr&#x000f6;m</surname><given-names>T</given-names></name><etal/></person-group><article-title>Long-term prognosis in patients with type 1 and 2 diabetes
mellitus after coronary artery bypass grafting</article-title><source>J Am Coll Cardiol</source><year>2015</year><volume>65</volume><issue>16</issue><fpage>1644</fpage><lpage>1652</lpage><pub-id pub-id-type="pmid">25908069</pub-id></element-citation></ref></ref-list></back></article>